Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor Inhibitor | Journal of Medicinal Chemistry
![Discovery of Pteridin-7(8H)-one-Based Irreversible Inhibitors Targeting the Epidermal Growth Factor Receptor (EGFR) Kinase T790M/L858R Mutant | Journal of Medicinal Chemistry Discovery of Pteridin-7(8H)-one-Based Irreversible Inhibitors Targeting the Epidermal Growth Factor Receptor (EGFR) Kinase T790M/L858R Mutant | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm401045n/asset/images/medium/jm-2013-01045n_0002.gif)
Discovery of Pteridin-7(8H)-one-Based Irreversible Inhibitors Targeting the Epidermal Growth Factor Receptor (EGFR) Kinase T790M/L858R Mutant | Journal of Medicinal Chemistry
Discovery of Pteridin-7(8H)-one-Based Irreversible Inhibitors Targeting the Epidermal Growth Factor Receptor (EGFR) Kinase T790M/L858R Mutant | Journal of Medicinal Chemistry
Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study | Journal of Medicinal Chemistry
![Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor Inhibitor | Journal of Medicinal Chemistry Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor Inhibitor | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.6b00995/asset/images/large/jm-2016-009954_0010.jpeg)
Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor Inhibitor | Journal of Medicinal Chemistry
![Discovery of Selective and Noncovalent Diaminopyrimidine-Based Inhibitors of Epidermal Growth Factor Receptor Containing the T790M Resistance Mutation | Journal of Medicinal Chemistry Discovery of Selective and Noncovalent Diaminopyrimidine-Based Inhibitors of Epidermal Growth Factor Receptor Containing the T790M Resistance Mutation | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm501578n/asset/images/large/jm-2014-01578n_0016.jpeg)
Discovery of Selective and Noncovalent Diaminopyrimidine-Based Inhibitors of Epidermal Growth Factor Receptor Containing the T790M Resistance Mutation | Journal of Medicinal Chemistry
![Discovery of Novel Allosteric EGFR L858R Inhibitors for the Treatment of Non-Small-Cell Lung Cancer as a Single Agent or in Combination with Osimertinib | Journal of Medicinal Chemistry Discovery of Novel Allosteric EGFR L858R Inhibitors for the Treatment of Non-Small-Cell Lung Cancer as a Single Agent or in Combination with Osimertinib | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c00893/asset/images/large/jm2c00893_0005.jpeg)
Discovery of Novel Allosteric EGFR L858R Inhibitors for the Treatment of Non-Small-Cell Lung Cancer as a Single Agent or in Combination with Osimertinib | Journal of Medicinal Chemistry
![Discovery of Pteridin-7(8H)-one-Based Irreversible Inhibitors Targeting the Epidermal Growth Factor Receptor (EGFR) Kinase T790M/L858R Mutant | Journal of Medicinal Chemistry Discovery of Pteridin-7(8H)-one-Based Irreversible Inhibitors Targeting the Epidermal Growth Factor Receptor (EGFR) Kinase T790M/L858R Mutant | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm401045n/asset/images/large/jm-2013-01045n_0007.jpeg)